COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease. La présente div...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
04.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
La présente divulgation concerne des anticorps anti-IL-34, des compositions les comprenant, et des procédés d'utilisation desdits anticorps et ou des compositions de ceux-ci pour traiter des maladies à médiation immunitaire telles que des maladies neurodégénératives, par exemple la maladie d'Alzheimer ou une tauopathie. |
---|---|
Bibliography: | Application Number: CA20223236560 |